Surgimab
Tumors detection tech
Surgimab has raised €6.6M across 1 funding round from 2 investors, most recently a round in Feb 2018. Based in France; active in Healthtech. Data as of 29 Oct 2026.
Total raised
€6.6M
€6,600,000
Funding rounds
1
Investors
2
distinct backers
Active since
2018-02
latest 2018-02
Funding by year
EUR raised per yearSurgimab — funding by year — interactive chart.
Data table
| Surgimab — funding by year | |
|---|---|
| 2018 | €6.6M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-02-01 | Other | €6.6M | Abalis Finance,Cathey World Investment | View deal → |
Investors
2Related news
Similar companies
same sector, similar size- M2i Life Sciences€6.8MFrance · Healthtech
- Prose€6.9MFrance · Healthtech
- Medicrea€7.2MFrance · Healthtech
- Concilio€6.0MFrance · Healthtech
- Physio-Assist€6.0MFrance · Healthtech
- Bruce€5.9MFrance · Healthtech
Global coverage: FundingData